Torsdag 10 September | 09:27:35 Europe / Stockholm
Svenska | English
Investor Relations
Public Relations
Kursutveckling under dagen för detta pressmeddelande (SEK).
Likviditet under dagen för detta pressmeddelande
Est. tid*
2027-02-19 08:30 Bokslutskommuniké 2026
2026-11-13 08:30 Kvartalsrapport 2026-Q3
2026-08-25 - Kvartalsrapport 2026-Q2
2026-05-08 - X-dag ordinarie utdelning ORTI B 0.00 SEK
2026-05-08 - X-dag ordinarie utdelning ORTI A 0.00 SEK
2026-05-07 - Årsstämma
2026-05-07 - Kvartalsrapport 2026-Q1
2026-02-20 - Bokslutskommuniké 2025
2025-11-28 - Kvartalsrapport 2025-Q3
2025-09-19 - Extra Bolagsstämma 2025
2025-08-25 - Kvartalsrapport 2025-Q2
2025-05-09 - X-dag ordinarie utdelning ORTI B 0.00 SEK
2025-05-09 - X-dag ordinarie utdelning ORTI A 0.00 SEK
2025-05-08 - Årsstämma
2025-05-08 - Kvartalsrapport 2025-Q1
2025-02-14 - Bokslutskommuniké 2024
2024-11-08 - Kvartalsrapport 2024-Q3
2024-08-23 - Kvartalsrapport 2024-Q2
2024-05-10 - X-dag ordinarie utdelning ORTI B 0.00 SEK
2024-05-10 - X-dag ordinarie utdelning ORTI A 0.00 SEK
2024-05-08 - Årsstämma
2024-05-08 - Kvartalsrapport 2024-Q1
2024-02-16 - Bokslutskommuniké 2023
2023-11-10 - Kvartalsrapport 2023-Q3
2023-08-25 - Kvartalsrapport 2023-Q2
2023-05-05 - X-dag ordinarie utdelning ORTI B 0.00 SEK
2023-05-05 - X-dag ordinarie utdelning ORTI A 0.00 SEK
2023-05-04 - Årsstämma
2023-05-04 - Kvartalsrapport 2023-Q1
2023-02-17 - Bokslutskommuniké 2022
2022-11-11 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-06 - X-dag ordinarie utdelning ORTI A 0.00 SEK
2022-05-06 - X-dag ordinarie utdelning ORTI B 0.00 SEK
2022-05-05 - Årsstämma
2022-04-27 - Kvartalsrapport 2022-Q1
2022-02-16 - Bokslutskommuniké 2021
2021-11-12 - Kvartalsrapport 2021-Q3
2021-08-20 - Kvartalsrapport 2021-Q2
2021-05-06 - X-dag ordinarie utdelning ORTI B 0.00 SEK
2021-05-06 - X-dag ordinarie utdelning ORTI A 0.00 SEK
2021-05-05 - Årsstämma
2021-04-27 - Kvartalsrapport 2021-Q1
2021-02-16 - Bokslutskommuniké 2020
2020-11-10 - Kvartalsrapport 2020-Q3
2020-08-21 - Kvartalsrapport 2020-Q2
2020-05-13 - X-dag ordinarie utdelning ORTI B 0.00 SEK
2020-05-13 - X-dag ordinarie utdelning ORTI A 0.00 SEK
2020-05-04 - Årsstämma
2020-04-23 - Kvartalsrapport 2020-Q1
2020-02-18 - Årsstämma
2020-02-13 - Årsstämma
2020-02-13 - Bokslutskommuniké 2019
2019-10-25 - Årsstämma
2019-08-22 - Kvartalsrapport 2019-Q2
2019-05-07 - X-dag ordinarie utdelning ORTI B 0.00 SEK
2019-05-07 - X-dag ordinarie utdelning ORTI A 0.00 SEK
2019-05-06 - Årsstämma
2019-05-03 - Kvartalsrapport 2019-Q1
2019-02-18 - Extra Bolagsstämma 2019
2019-02-13 - Bokslutskommuniké 2018
2018-11-20 - Kvartalsrapport 2018-Q3
2018-08-24 - Kvartalsrapport 2018-Q2
2018-05-04 - X-dag ordinarie utdelning ORTI B 0.00 SEK
2018-05-04 - X-dag ordinarie utdelning ORTI A 0.00 SEK
2018-05-03 - Årsstämma
2018-04-30 - Kvartalsrapport 2018-Q1
2018-02-08 - Bokslutskommuniké 2017
2017-11-21 - Kvartalsrapport 2017-Q3
2017-08-22 - Kvartalsrapport 2017-Q2
2017-05-12 - Extra Bolagsstämma 2017
2017-05-02 - X-dag ordinarie utdelning ORTI B 0.00 SEK
2017-05-02 - X-dag ordinarie utdelning ORTI A 0.00 SEK
2017-05-02 - Kvartalsrapport 2017-Q1
2017-04-28 - Årsstämma
2017-02-10 - Bokslutskommuniké 2016
2016-10-24 - Kvartalsrapport 2016-Q3
2016-07-13 - Kvartalsrapport 2016-Q2
2016-05-09 - Årsstämma
2016-05-02 - Kvartalsrapport 2016-Q1
2016-04-30 - X-dag ordinarie utdelning ORTI B 0.00 SEK
2016-04-30 - X-dag ordinarie utdelning ORTI A 0.00 SEK
2016-02-10 - Bokslutskommuniké 2015
2015-10-20 - Kvartalsrapport 2015-Q3
2015-07-13 - Kvartalsrapport 2015-Q2
2015-04-30 - X-dag ordinarie utdelning ORTI B 0.00 SEK
2015-04-30 - X-dag ordinarie utdelning ORTI A 0.00 SEK
2015-04-29 - Årsstämma
2015-04-29 - Kvartalsrapport 2015-Q1
2015-02-17 - Bokslutskommuniké 2014
2014-10-27 - Kvartalsrapport 2014-Q3
2014-07-11 - Kvartalsrapport 2014-Q2
2014-04-30 - X-dag ordinarie utdelning ORTI B 0.00 SEK
2014-04-30 - X-dag ordinarie utdelning ORTI A 0.00 SEK
2014-04-29 - Årsstämma
2014-04-29 - Kvartalsrapport 2014-Q1
2014-02-07 - Bokslutskommuniké 2013
2013-10-18 - Kvartalsrapport 2013-Q3
2013-07-12 - Kvartalsrapport 2013-Q2
2013-04-30 - Kvartalsrapport 2013-Q1
2013-04-22 - X-dag ordinarie utdelning ORTI B 0.00 SEK
2013-04-22 - X-dag ordinarie utdelning ORTI A 0.00 SEK
2013-04-19 - Årsstämma
2013-02-08 - Bokslutskommuniké 2012
2012-10-18 - Kvartalsrapport 2012-Q3
2012-07-12 - Kvartalsrapport 2012-Q2
2012-05-04 - X-dag ordinarie utdelning ORTI B 0.00 SEK
2012-05-04 - X-dag ordinarie utdelning ORTI A 0.00 SEK
2012-05-03 - Årsstämma
2012-04-20 - Kvartalsrapport 2012-Q1
2012-02-22 - Bokslutskommuniké 2011
2011-10-14 - Kvartalsrapport 2011-Q3
2011-08-12 - Kvartalsrapport 2011-Q2
2011-05-31 - Extra Bolagsstämma 2010
2011-05-05 - X-dag ordinarie utdelning ORTI B 0.00 SEK
2011-05-05 - X-dag ordinarie utdelning ORTI A 0.00 SEK
2011-05-04 - Årsstämma
2011-04-15 - Kvartalsrapport 2011-Q1
2011-02-18 - Bokslutskommuniké 2010
2010-10-14 - Kvartalsrapport 2010-Q3
2010-08-12 - Kvartalsrapport 2010-Q2
2010-05-04 - X-dag ordinarie utdelning ORTI B 0.00 SEK
2010-05-04 - X-dag ordinarie utdelning ORTI A 0.00 SEK
2010-05-03 - Årsstämma
2010-04-22 - Kvartalsrapport 2010-Q1
2010-02-19 - Bokslutskommuniké 2009
2009-11-12 - Kvartalsrapport 2009-Q3
2009-08-14 - Kvartalsrapport 2009-Q2
2009-05-07 - X-dag ordinarie utdelning ORTI B 0.00 SEK
2009-05-07 - X-dag ordinarie utdelning ORTI A 0.00 SEK
2009-05-06 - Årsstämma
2009-05-06 - Kvartalsrapport 2009-Q1
1998-04-23 - Split ORTI A 1:2
LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Ortivus är verksamt inom hälsovårdssektorn. Bolaget är specialiserade inom utvecklingen av mobila lösningar för sjukvården. Tjänsterna innefattar exempelvis övervaknings- och kommunikationslösningar som vidare används inom beslut- och stödsystem. Idag vidaresäljs lösningarna under flertalet varumärken med vardera affärsinriktning. Störst verksamhet innehas inom Norden, samt Europa. Ortivus etablerades under 1985 och har sitt huvudkontor i Danderyd.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Interim Report for Ortivus AB (publ) for the period April – June 2026

2026-08-25 08:30:00

“Ortivus’ deep domain knowledge and advancements in AI mean that we, with the MobiMed platform, are well positioned to meet the healthcare sector’s urgent need for increased efficiency.”

April-June 2026

  • Net sales decreased by 2% compared to the same period last year and amounted to SEK 19.3 (19.7) million.
  • The gross margin decreased to 37 (51)%.
  • EBITDA amounted to SEK -2.8 (-4.7) million.
  • Net profit after tax amounted to SEK -3.6 (-6.5) million.
  • Earnings per share before and after dilution amounted to SEK -0.04 (-0.15).

 
January-June 2026

  • Net sales increased by 8% compared to the same period last year and amounted to SEK 40.8 (37.8) million.
  • The gross margin decreased to 42 (46)%.
  • EBITDA amounted to SEK -2.9 (-6.1) million.
  • Net profit after tax amounted to SEK -4.9 (-8.9) million.
  • Earnings per share before and after dilution amounted to SEK -0.06 (-0.20).

 
Significant events during and after the end of the period

  • In April, Ortivus announced the appointment of Matti Zemack as the company’s new Chief Product Officer. Zemack will be responsible for the company’s product vision and product development and will lead the next generation of Ortivus’ innovative medical technology solutions within e-health.
  • In April, Ortivus held its annual User Forum in Southampton, UK. With strong participation from our UK customers, new solutions within the MobiMed platform were presented and discussed.
  • In May, Ortivus announced that the company had divested all its shares in the technology company H&E Solutions AB for a purchase price of SEK 5.2 million. The sale generated an accounting profit of SEK 2.9 million and strengthened Ortivus’ liquidity, while the successful collaboration on MobiMed enRoute continued unchanged.
  • Ortivus held its Annual General Meeting on 27 May 2026.
  • In July, Ortivus strengthened the MobiMed platform with AI-based clinical documentation through a new partnership with Tortus AI.
  • Ortivus intends to transition to semi-annual financial reporting, meaning that the interim report for the third quarter, previously scheduled for 13 November 2026, will not be published. The company’s next financial report will therefore be the Year-End Report for 2026.

Contacts

For further information, please contact

Gustaf Nordenhök, CEO

Phone +46 8 446 45 00

About Ortivus

Ortivus has extensive experience in mobile communication solutions and a unique understanding of clinical healthcare. We develop interactive and user-friendly solutions that support diagnostics, increase efficiency, and deliver long-term cost savings for healthcare providers. By integrating our solutions with electronic health records, dispatch systems, and national registries, we ensure fast and secure information management, a crucial factor in creating a more integrated care process. 
 
Our solutions save valuable time for healthcare professionals, optimise resource use, and reduce the need for avoidable patient transports, resulting in more cost-effective and patient-centred care. With our combination of advanced technology and deep clinical expertise, we support our customers in meeting the healthcare challenges of today and tomorrow.

Ortivus Class A and Class B shares are listed on the NASDAQ First North Growth Market and the company’s Certified Adviser is FNCA Sweden AB.
 
Read more about our solutions at www.ortivus.com

This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-08-25 08:30 CEST.

Attachments

Interim Report April June 2026

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Företag
Pressmeddelanden